Page Views: 91 Date Added: 09/14/2011 Last Updated: 09/14/2011 Expiry Date: 09/11/2021 Product/Service Details Hu Gan Tablets Chronic Hepatitis,Early Cirrhosis 100tablets/bottle*100bottle Ingredient:Radix Bupleuri Chinensis, Herba Artemisiae Capillaris, Radix Isatidis, Fructus Schisandrae Chinensis, Pig Gall Powder, Semen Vignae Radiatae. Action and Indications:Soothing liver and regulating vital energy, invigorating spleen to promote digestion. Possess to decrease Transaminase Action. Utendus Chronic Hepatitis and prophase Liver Cirrhosis, Fatty Liver, 1\Hepatoprotection And Decrease Enzymes: Radix Bupleuri Chinensis, Herba Artemisiae Capillaris, Radix Isatidis and Fructus Schisandrae Chinensis possess obvious reduction effect byCCl4, Thioacetamide, D-Galactosamine and Paracetamol Chemistry Poisons originated animal Acute and Chronic Injury of Liver originated Serum Glutamic Pyruvic Ransaminase Activity Step-up, at equal pace, it has alleviated effect to originated hepatic cells damage. 2\Increase liver antipyresis antitoxicant ability: Induce liver drug enzyme: deoxyschizandrin, Schizandrin B, Schisandrin C, Capillarisin and Arcapillin obviously induce hepatic cells microsomes cytochrome P450 activity and content obviously increase, promote liver drug enzyme synthesis and enhance liver drug enzyme activity. Inhibit enzymic activity: Capillarisin, 6,7-Escoparone and Arcapillin restrain β-Glycuronidase activity, decrease Glycuronic Acid to decompose. 3\Repair injured liver cells: Promote liver glycogen and liver protein synthesis, promote liver cell multiplication, resist cellular oxidation and aging, stable cell membrane and anti-inflammatory action. 4\Block hepatic cells fibration: Schizandrin B decrease the hydroxy lamine acid content of liver, illustrate that the collagen content of liver reduce, lighten fibration. Radix Bupleuri Chinensis possess to restrain fiber hyperplasia and promote fiber absorption, and block liver cells fibration. 5\Restrain liver cells fatty degeneration: Decrease blood fat, promote fat metabolism, decrease cholesterol, promote digestion and absorption, promote bilification and elimination. 6\Increase organism immunity: Fructus Schisandrae Chinensis can promote immunocyte differentiation, restrain immunologic rejection. Radix Isatidis polysaccharides and saikoside can obviously increase spleen cell DNA synthesis, enhance the phagocytosis ability of reticuloendothelial system. 7\Restrain hepacivirus: Radix Bupleuri Chinensis and Herba Artemisiae Capillaris in vitro restrain HBV. Radix Isatidis promote hbsag carrier HBsAg\HBeAg darkening.

Company Information (Xiuzheng Pharmaceutical Group International Trading CO.,LTD)

Company Profile: Xiuzheng Pharmaceutical Group, founded in 1995 by the chairman of the board Mr. XiuLaigui, is one of the largest modern pharmaceutical enterprises in China, which is dedicated to R&D, manufacturing and marketing of Chinese traditional medicine, chemical medicine and biological medicine worldwide. Xiuzheng also owns a chain drugstore and planting bases focusing on standardized planting and processing of herbs. The architect of developing Xiuzheng is formed by One national class enterprise technical center, Five bases for raw medical material, Eight pharmaceutical bases and Fifteen sales systems. Xiuzheng had 45 wholly-owned subsidiaries, over 60,000 employees and total assets of 14.2 billion yuan. Xiuzheng ranked the 1st among the pharmaceutical enterprises of Jilin province from 2000 to 2007, and was No.1 in the profit ranking of traditional Chinese medicine enterprises in 2004. The total sales income of Xiuzheng has exceeded 20 billion yuan, with total amount of tax paid over 1.1 billion yuan and a profit of 2.95 billion yuan by 2007. In 2007, the sales income of Xiuzheng exceeded 5.7 billion yuan. In 2008, the total output value of Xiuzheng exceeded 7.9 billion yuan with 7.6 billion yuan of sales income and 600 million yuan of total pre-tax profits, In 2010, the sales income of Xiuzheng exceeded 18 billion yuan,heading the list of national pharmaceutical enterprises. Xiuzheng now manufactures more than 800 different drugs and pharmaceuticals and about 1,000 health care products. The brands of Xiuzheng and Sidashu win the honor of Chinese Well-Known Marks. By now Xiuzheng has awarded hundreds of honors such as the National Contract-honoring, the Promise-keeping Enterprise, the National Torch Plan Project Superior Hi-tech Enterprise and the National Scientific and Technological Innovation Spark Plan Leading Enterprise, etc. Xiuzheng has a national enterprise technical center, a national engineering center and a post-doctoral workstation, with more than 500 technical personnel, many of whom are qualified with senior professional titles. Xiuzheng also established long-term cooperation with universities and research institutions to further upgrading the capabilities in pharmaceutical research and development. Xiuzheng also cares much about charity work and public welfare work, and has so far donated more than 350 million yuan and supplies over 60,000 job opportunities for the society. Xiuzheng is aiming at being the best pharmaceutical enterprise in China and plans to achieve more than 25 billion yuan of sales income in 2011.. >> More Website URL: http://www.bridgat.com/u44913